Safety and Tolerability of a Rapid Transition From Intravenous Treprostinil to Oral Selexipag in Three Adolescent Patients With Pulmonary Arterial Hypertension

There is limited published experience with transitioning pediatric patients from parenteral treprostinil to oral selexipag therapy. In addition, published transitions have typically been protracted, taking several weeks to complete. We present a case series of 3 adolescent patients who were transiti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pediatr Pharmacol Ther
Autores principales: Colglazier, Elizabeth, Ng, Angelica J., Parker, Claire, Nawaytou, Hythem, Fineman, Jeffrey R.
Formato: Artigo
Lenguaje:Inglês
Publicado: Pediatric Pharmacy Advocacy Group 2021
Materias:
Clinical Vignette
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8244952/
https://ncbi.nlm.nih.gov/pubmed/34239406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-26.5.512
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares